Abpro Holdings Inc share price logo

Abpro Holdings Inc Share Price

NASDAQ: ABP

$0.52

-0.28

(-34.75%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 20 Feb 2026

Abpro Holdings Inc Stock Performance

as on February 21, 2026 at 7:59 am IST

  • Day's High

    $0.52
    $0.78

    50.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.52
    $18.57
    downward going graph

    0.57%

    Downside

    3470.87%

    Upside

    downward going graph

Abpro Holdings Inc share price movements today

Previous Close
$0.80
Open
$0.76
Volume
1.5M
Day's Low - High
$0.52 - $0.78
52 Week Low - High
$0.52 - $18.57

Abpro Holdings Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Abpro Holdings Inc Stock Fundamentals & Key Indicators

Check Abpro Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Abpro Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abpro Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$-NANA0.00%
BUY$43.9B124.79%142.788.45%
BUY$122.0B133.75%31.3432.94%
NA$35.7BNA619.941.38%
BUY$81.5B73.48%18.5931.41%

Abpro Holdings Inc Stock’s Investor Sentiment and Interest

Investment in Abpro Holdings Inc Shares on INDmoney has grown by 1580.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1580.00% versus previous 30 day period

Abpro Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
-
-
0
0
-
-
-
Gross Profit
-1
2
0
0
0
1
0
-
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
0
-14
0
-2
0
-5
-3
-2
-1
Net Profit Margin
-10844.00%
-178.52%
-11913.93%
0.00%
0.00%
-183.06%
-3010.38%
0.00%
0.00%
0.00%

Abpro Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
2
0
2
0
0
Gross Profit
0
0
-8
-7
0
0
Operating Income
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
Net Income
-5
-12
-14
-17
-11
-7
Net Profit Margin
-327.24%
-561.43%
-3069.79%
-848.45%
-9595.08%
-3951.91%

Insights on Abpro Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 41.8% return, outperforming this stock by 139.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.2% return, outperforming this stock by 157.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABP stock has moved down by -29.5%

About Abpro Holdings Inc

Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
OrganisationAbpro Holdings Inc
E-voting on sharesClick here to vote

FAQs

What is Abpro Holdings Inc share price today?

Abpro Holdings Inc share price today is $0.52 as on at the close of the market. Abpro Holdings Inc share today touched a day high of $0.78 and a low of $0.52.

What is the 52 week high and 52 week low for Abpro Holdings Inc share?

Abpro Holdings Inc share touched a 52 week high of $18.57 on and a 52 week low of $0.52 on . Abpro Holdings Inc stock price today i.e. is closed at $0.52,which is 97.20% down from its 52 week high and 0.57% up from its 52 week low.

How to invest in Abpro Holdings Inc Stock (ABP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abpro Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abpro Holdings Inc Shares that will get you 2.8846 shares as per Abpro Holdings Inc share price of $0.52 per share as on February 21, 2026 at 2:29 am IST.

What is the minimum amount required to buy Abpro Holdings Inc Stock (ABP) from India?

Indian investors can start investing in Abpro Holdings Inc (ABP) shares with as little as ₹91.026 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹910.26 in Abpro Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Abpro Holdings Inc share’s latest price of $0.52 as on February 21, 2026 at 2:29 am IST, you will get 19.2308 shares of Abpro Holdings Inc. Learn more about fractional shares .